Mallinckrodt’s stock soars 12% on Q4 results beat
Mallinckrodt plc (MNK) topped market expectations on revenue and earnings for the fourth quarter of 2018, sending the shares soaring...
Health Care
Immunomedics tanks after CEO Michael Pehl’s exit and ‘transition period’ results
Immunomedics (IMMU) plunged about 10% in the extended trading hours after the company announced about CEO Michael Pehl’s exit from...
Earnings preview: Amarin likely to deliver strong Q4 results
Amarin Corporation (AMRN) is scheduled to report earnings results for the fourth quarter of 2018 on Wednesday, February 27, before...
Earnings Preview: GW Pharma to widen losses in to-be-reported quarter
GW Pharmaceuticals PLC (GWPH) is expected to post its quarterly earnings on Feb. 26. Last week, GW Pharma saw its...
Amarin shares jump 14% on rumors over Novartis interest
Shares of Amarin Corp (AMRN) gained up to 14% during the regular trading hours on Friday as rumors of an...
Earnings preview: Immunomedics might deliver lower revenue for Q2
Immunomedics Inc. (IMMU) is scheduled to report second-quarter 2019 earnings results on Monday, February 25, after market close. The consensus...
Immune Design stock more than triples as it gets acquired by Merck
Merck (MRK) announced today that it will acquire immunotherapy developer Immune Design (IMDZ) for $5.85 per share in cash for an...
Agilent Technologies stock drops despite beating Q1 estimates
Agilent Technologies (A) stock dropped about 4% in the extended trading hours despite reporting upbeat Q1 results. The muted guidance...
Tilray resumes deal spree, signs fifth in 2 months
Tilray Inc. (TLRY) has taken the fusion spree seriously as a new deal has been signed to buy hemp food...
Bausch Health’s stock rises after Q4 revenue beats estimates
Bausch Health Companies Inc. (BHC) topped revenue estimates for the fourth quarter of 2018, sending shares climbing by 2.8% in...
Aurora Cannabis shuffles its board of directors
Aurora Cannabis (ACB) on Wednesday announced the shuffle to its board of directors for aligning the directors’ experience and expertise...
CVS Health reports mixed Q4 results; stock falls over 7%
CVS Health Corporation (CVS) reported better-than-expected earnings for the fourth quarter of 2018 but revenue fell short of estimates, sending...
Intercept stock surges on positive data from liver fibrosis drug study
Intercept Pharmaceuticals (ICPT) had surged about 25% in the pre-market session on Tuesday after the biopharma company announced positive topline...
Medtronic beats Q3 estimates and raises full-year guidance
Medtronic plc (MDT) topped consensus estimates on revenue and earnings for the third quarter of 2019 and raised its earnings...
CVS Health Q4 earnings preview: What to expect
CVS Health Corporation (CVS) is scheduled to report fourth-quarter earnings results before the regular trading hours on Wednesday, February 20....
Earnings preview: Medtronic could benefit from innovation, global expansion in Q3
Medical technology company Medtronic (MDT) will be reporting financial results for the third quarter Tuesday before the market opens. Analysts’...
Canopy Growth misses Q3 estimates
Canopy Growth (TSX: WEED, NYSE: CGC) reported a loss of CAD0.38 and revenue of CAD83 million, which missed analysts’ predictions. Analysts...
Quest Diagnostics Q4 profit drops 50%, misses estimates
Quest Diagnostics (DGX) reported a 50% drop in earnings for the fourth quarter due to a decline in net revenues,...
Earnings: Oncology unit drives AstraZeneca topline higher in Q4
AstraZeneca Plc (AZN) reported a 22% dip in earnings for the fourth quarter to 82 cents per share, weighed down...
Johnson & Johnson buys Auris Health to boost medical devices business
Establishing its foray into robotic health products, pharmaceutical giant Johnson & Johnson (JNJ) on Wednesday announced it was acquiring California-based...
Earnings: Teva Pharma shrinks Q4 losses, but revenue falls
Teva Pharma (TEVA) posted its fourth-quarter 2018 before the opening bell on Feb. 13. The generic drugmaker saw revenue slip 16%...